FDA approves the first generic naloxone nasal spray to treat opioid overdoses

Cross-posted from Optum Insights blog. On April 19, the U.S. Food and Drug Administration (FDA) approved the first generic for Narcan® Nasal Spray, the life-saving medication used for the emergency treatment of opioid-related overdose. After receiving tentative approval last June, Teva Pharmaceuticals USA Inc. has been granted final approval to market naloxone nasal spray. Teva … Read moreFDA approves the first generic naloxone nasal spray to treat opioid overdoses

Prescription drug updates may positively affect Medicare Set Aside

As part of our best business practices, we continually monitor RED BOOK®Average Wholesale Price (AWP) of the most common medications present in Workers’ Compensation Medicare Set-Aside (WCMSA) arrangements. This practice assists in identifying price changes positively affecting WCMSAs. The month of February brought price drops of the following medications: buprenorphine/naloxone (Suboxone®) commonly prescribed for opioid … Read morePrescription drug updates may positively affect Medicare Set Aside